| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2008 | WO2008001086A1 Nutritional formulation |
| 01/03/2008 | WO2008001079A1 Methods for identifying modulators of eoxin formation |
| 01/03/2008 | WO2008001076A1 Fused thiazole derivatives as kinase inhibitors |
| 01/03/2008 | WO2008001070A1 Pyrimidine derivatives useful in the treatment of cancer |
| 01/03/2008 | WO2008001055A1 Polyether polyols for use in the treatment and/or prevention of inflammatory lung disease |
| 01/03/2008 | WO2008001053A1 Treatment and/or prevention of pain using polyether polyols |
| 01/03/2008 | WO2008001016A1 Use of a carbonic anhydrase inhibitor for preparation of a drug for treating skeletal muscle degeneration |
| 01/03/2008 | WO2008000968A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | WO2008000967A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | WO2008000950A2 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 01/03/2008 | WO2008000922A1 Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 01/03/2008 | WO2008000920A1 D-glucopyranose 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxybenzoate] compound and its derivatives, preparation thereof and uses thereof |
| 01/03/2008 | WO2008000839A1 Quinolinone derivatives and their pharmaceutical compositions |
| 01/03/2008 | WO2008000818A1 Fluorinated indoleamides useful as ligands of the orl-1 receptor |
| 01/03/2008 | WO2008000777A2 Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use |
| 01/03/2008 | WO2008000760A1 Flibanserin for the treatment of urinary incontinence and related diseases |
| 01/03/2008 | WO2008000749A1 Detection of esr1 amplification in breast cancer |
| 01/03/2008 | WO2008000745A2 Adenosine derivatives for the treatment of pain |
| 01/03/2008 | WO2008000744A2 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 01/03/2008 | WO2008000743A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 01/03/2008 | WO2008000731A2 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids |
| 01/03/2008 | WO2008000729A1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 01/03/2008 | WO2008000697A1 Novel 4-amino-3-(-azolyl-phenoxymethyl)-thieno[3,2]pyridine-7-carboxylic acid derivatives |
| 01/03/2008 | WO2008000692A2 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 01/03/2008 | WO2008000683A1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 01/03/2008 | WO2008000669A1 Improving tolerance to anti-inflammatories |
| 01/03/2008 | WO2008000645A1 Tetrazole-substituted arylamides |
| 01/03/2008 | WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
| 01/03/2008 | WO2008000549A1 Use of defibrotide for the inhibition of heparanase |
| 01/03/2008 | WO2008000521A1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same |
| 01/03/2008 | WO2008000513A2 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/03/2008 | WO2008000512A2 Method for identifying crmp modulators |
| 01/03/2008 | WO2008000495A1 Use of 5-ht7 receptor agonists for the treatment of pain |
| 01/03/2008 | WO2008000484A1 Verfahren zur herstellung von pentamethylen-1,5-diisocyanat |
| 01/03/2008 | WO2008000483A2 Phenol derivatives for the treatment of respiratory diseases |
| 01/03/2008 | WO2008000482A1 Compositions of glycopyrronium salt for inhalation |
| 01/03/2008 | WO2008000469A2 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
| 01/03/2008 | WO2008000463A2 Rabeprazole formulation |
| 01/03/2008 | WO2008000448A2 Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles |
| 01/03/2008 | WO2008000447A1 New formulation for increasing bioavailability of neurturin |
| 01/03/2008 | WO2008000440A1 Use of a polyunsaturated fatty acid compound |
| 01/03/2008 | WO2008000429A2 Polymers with antimicrobial activity containing quaternary ammonium groups |
| 01/03/2008 | WO2008000423A1 Crystalline form of cinacalcet |
| 01/03/2008 | WO2008000422A1 Amorphous form of cinacalcet |
| 01/03/2008 | WO2008000421A2 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 01/03/2008 | WO2008000420A1 Pharmaceutical composition comprising tetrahydrolipstatin |
| 01/03/2008 | WO2008000419A1 S1p receptor modulators for treating multiple sclerosis |
| 01/03/2008 | WO2008000410A1 Cxcr2 inhibitors |
| 01/03/2008 | WO2008000409A1 New cxcr2 inhibitors |
| 01/03/2008 | WO2008000408A1 Cxcr2 antagonists |
| 01/03/2008 | WO2008000407A1 Inhibitors of cxcr2 |
| 01/03/2008 | WO2008000260A1 Compositions with several hyaluronic acid fractions for cosmetic and medical uses |
| 01/03/2008 | WO2008000194A1 Extended release solid pharmaceutical composition containing carbidopa and levodopa |
| 01/03/2008 | WO2008000142A1 Dopamine transporter agonist and its use |
| 01/03/2008 | WO2008000131A1 α-AMINO-N-SUBSTITUTED AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF |
| 01/03/2008 | WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | WO2008000070A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | WO2008000042A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/03/2008 | WO2008000040A1 A stabilised composition comprising ace inhibitors |
| 01/03/2008 | WO2007134077A3 5 ht receptor mediated neurogenesis |
| 01/03/2008 | WO2007133756A3 Crf1 receptor ligands comprising heteroaryl fused bicycles |
| 01/03/2008 | WO2007133637A3 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 01/03/2008 | WO2007130822A3 Mglur5 modulators iii |
| 01/03/2008 | WO2007128829A3 18,21-didesoxymacbecin derivatives for the treatment of cancer |
| 01/03/2008 | WO2007128827A8 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies |
| 01/03/2008 | WO2007128564A3 Use of a compound with rankl activity |
| 01/03/2008 | WO2007127726A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/03/2008 | WO2007127502A3 Polymorphic form of { 2-methyl-4- [ 4-methyl-2- ( 4-triflu0r0methylphenyl) thiazol -5- ylmethylthiol phenoxy }-acetic acid |
| 01/03/2008 | WO2007126900A3 Antifungal agents |
| 01/03/2008 | WO2007125331A3 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 01/03/2008 | WO2007124005A3 Methods for treating bone associated diseases by the use of methionine aminopeptidase-2 inhibitors |
| 01/03/2008 | WO2007123984A3 Pre-mixed, ready-to-use pharmaceutical compositions |
| 01/03/2008 | WO2007121279A3 Cancer treatment method |
| 01/03/2008 | WO2007120729A3 Pyridyl amide t-type calcium channel antagonists |
| 01/03/2008 | WO2007120600A3 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/03/2008 | WO2007120385A3 Low flush niacin formulation |
| 01/03/2008 | WO2007118198A3 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/03/2008 | WO2007117961A3 Renin inhibitors |
| 01/03/2008 | WO2007117467A3 Use of tm-601 for the diagnosis and treatment of tumors |
| 01/03/2008 | WO2007117289A3 Methods for treating or preventing erectile dysfunction or urinary incontinence |
| 01/03/2008 | WO2007113698A3 Preventative treatment and remission of allergic diseases |
| 01/03/2008 | WO2007113391A3 Use of inositol |
| 01/03/2008 | WO2007113243A3 Use of pde 5 inhibitors for the treatment of overactive bladder |
| 01/03/2008 | WO2007113005A3 2-substituted 3-aminosulfonyl-thiophene derivatives as aurora kinase inhibitors |
| 01/03/2008 | WO2007112121A3 Tetracycline compounds and methods of treatment |
| 01/03/2008 | WO2007112036A3 Modified macrophage migration inhibitory factor inhibitors |
| 01/03/2008 | WO2007107696A3 Pharmaceutically acceptable salts and polymorphic forms |
| 01/03/2008 | WO2007104573A3 Improved snuff composition |
| 01/03/2008 | WO2007103563A3 Pharmaceutical formulations containing metformin |
| 01/03/2008 | WO2007102052A3 Foam containing unique oil globules |
| 01/03/2008 | WO2007099409A3 Therapeutic compositions containing trimethoprim and cranberry extract and methods for treating and preventing urinary tract infections |
| 01/03/2008 | WO2007098381A3 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 01/03/2008 | WO2007098281A3 Oxysterol compounds and the hedgehog pathway |
| 01/03/2008 | WO2007096703A3 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 01/03/2008 | WO2007092705A3 Process for preparing gemcitabine and associated intermediates |
| 01/03/2008 | WO2007089904A3 Pyridylphenyl compounds for inflammation and immune-related uses |
| 01/03/2008 | WO2007089733A3 Regimens for treatment of conditions related to estrogen deficiency |
| 01/03/2008 | WO2007089679A3 Potassium channel inhibitors |
| 01/03/2008 | WO2007089657A3 Crystalline forms of a farnesyl dibenzodiazepinone |